Shikonin administration by gavage to the rat model of vascular dementia at a dose of 10 mg/kg/day resulted in improved morphological changes in the CA1 region of the hippocampal neurons by down-regulating the expression of p-Akt, p-PTEN, p-CREB, and BDNF. This evidence concerns the gene CREB1 and vascular dementia.